While sustainability-linked bonds have come in for some criticism, they have the potential to dominate the roughly $6 trillion ethical debt market.
It's a turbulent time for ESG in the U.S., but financial advisors can benefit from learning more about the topic, Maria Lettini says.
Many of the top US fund companies have exposure to companies that make controversial weapons, As You Sow found.
A campaign against the use of ESG factors to manage assets for public workers has snowballed; the issue has also been a focus in Congress.
More than three million shareholder accounts in BlackRock's iShares Core S&P 500 ETF will be able to vote.
For example, artificial intelligence could help with the threat of deforestation by tracking 'land use change and geospatial mapping.'
The House Financial Services Committee heard testimony on 18 bills that would curtail SEC efforts or otherwise restrict ESG considerations.
Jennifer Kenning wants to bring the role of relationships back to wealth management.
House Republicans have planned six hearings in their anti-ESG blitz, along with bill markups dedicated to the topic.
Republican lawmakers fired off letters to financial industry giants warning their efforts to combat climate change could violate antitrust law.
A plaintiff alleges that ESG led to lower returns, but the case brought against American Airlines' defined-contribution plan might be more political than substantive.
A quarter of sustainability-linked bonds, which typically pay higher interest if the issuer misses ESG targets, can be redeemed before any penalty is triggered, according to a new report.
Less than 1% of active sustainable funds have investments in tobacco producers, data from Morningstar Direct show.
Regulatory changes, social pressure and demand from clients are keeping fund companies focused on ESG, according to a survey.
The voluntary framework published by the International Sustainability Standards Board paves the way for companies across jurisdictions to report uniform climate and sustainability information.
The list of priorities put together by the House Committee on Financial Services' ESG working group shows where a Republican administration might be headed.
There are lessons in the data for politicians who are pro- or anti-ESG, but the numbers might be dismissed.
The measure, which could survive the governor's veto, would still allow ESG factors that are 'pecuniary.'
Pricing, product governance and legal liabilities are some of the factors to consider when assessing drug companies.
Investors who see risk associated with ESG are in for a surprise.
